Iteos Therapeutics Inc (ITOS) — Capital Reinvestment Ratio
Iteos Therapeutics Inc (ITOS) has a Capital Reinvestment Ratio of 0.03x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.50 Million) in capital expenditures ($152.00K). See Iteos Therapeutics Inc (ITOS) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Iteos Therapeutics Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Iteos Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check ITOS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Iteos Therapeutics Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Iteos Therapeutics Inc from 2021 to 2021. For live market cap and broader valuation context, see market value of Iteos Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $513.14 Million | $1.18 Million | — |